280 related articles for article (PubMed ID: 9195019)
1. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
Vogel C; Donat S; Döhr O; Kremer J; Esser C; Roller M; Abel J
Arch Toxicol; 1997; 71(6):372-82. PubMed ID: 9195019
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
3. Effect of transforming growth factor-beta1 on cytochrome P450 expression: inhibition of CYP1 mRNA and protein expression in primary rat hepatocytes.
Müller GF; Döhr O; El-Bahay C; Kahl R; Abel J
Arch Toxicol; 2000 May; 74(3):145-52. PubMed ID: 10877000
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cytochrome P450 1 (Cyp1) by vanadium in hepatic tissue and isolated hepatocyte of C57BL/6 mice.
Abdelhamid G; Amara IE; Anwar-Mohamed A; El-Kadi AO
Arch Toxicol; 2013 Aug; 87(8):1531-43. PubMed ID: 23423713
[TBL] [Abstract][Full Text] [Related]
5. Physiological modeling of a proposed mechanism of enzyme induction by TCDD.
Kohn MC; Walker NJ; Kim AH; Portier CJ
Toxicology; 2001 May; 162(3):193-208. PubMed ID: 11369115
[TBL] [Abstract][Full Text] [Related]
6. Effect of gestational and lactational 2,3,7, 8-tetrachlorodibenzo-p-dioxin exposure on the level and catalytic activities of hepatic microsomal CYP1A in prepubertal and adult rats.
Iba MM; Fung J; Cooper KR; Thomas PE; Wagner GC; Park Y
Biochem Pharmacol; 2000 May; 59(9):1147-54. PubMed ID: 10704945
[TBL] [Abstract][Full Text] [Related]
7. For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential.
Dragin N; Dalton TP; Miller ML; Shertzer HG; Nebert DW
J Biol Chem; 2006 Jul; 281(27):18591-600. PubMed ID: 16636061
[TBL] [Abstract][Full Text] [Related]
8. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
9. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells.
Nakajima M; Iwanari M; Yokoi T
Toxicol Lett; 2003 Sep; 144(2):247-56. PubMed ID: 12927368
[TBL] [Abstract][Full Text] [Related]
10. Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria.
Walker NJ; Crofts FG; Li Y; Lax SF; Hayes CL; Strickland PT; Lucier GW; Sutter TR
Carcinogenesis; 1998 Mar; 19(3):395-402. PubMed ID: 9525272
[TBL] [Abstract][Full Text] [Related]
11. Methoxyresorufin: an inappropriate substrate for CYP1A2 in the mouse.
Hamm JT; Ross DG; Richardson VM; Diliberto JJ; Birnbaum LS
Biochem Pharmacol; 1998 Dec; 56(12):1657-60. PubMed ID: 9973187
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of avian CYP1A4 and CYP1A5 by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: differences in gene expression and regulation compared to mammalian CYP1A1 and CYP1A2.
Mahajan SS; Rifkind AB
Toxicol Appl Pharmacol; 1999 Feb; 155(1):96-106. PubMed ID: 10036222
[TBL] [Abstract][Full Text] [Related]
13. 2,3,7,8 Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes.
Xu L; Li AP; Kaminski DL; Ruh MF
Chem Biol Interact; 2000 Feb; 124(3):173-89. PubMed ID: 10728777
[TBL] [Abstract][Full Text] [Related]
14. Effect of sulfur dioxide inhalation on CYP1A1 and CYP1A2 in rat liver and lung.
Qin G; Meng Z
Toxicol Lett; 2005 Dec; 160(1):34-42. PubMed ID: 16023800
[TBL] [Abstract][Full Text] [Related]
15. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
16. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of vitamin A on TCDD-induced cytochrome P-450 1A1 enzyme activity and expression.
Yang YM; Huang DY; Liu GF; Zhong JC; Du K; Li YF; Song XH
Toxicol Sci; 2005 May; 85(1):727-34. PubMed ID: 15728703
[TBL] [Abstract][Full Text] [Related]
18. Significant interspecies differences in induction profiles of hepatic CYP enzymes by TCDD in bank and field voles.
Murtomaa-Hautala M; Korkalainen M; Pelkonen O; Hegde N; Pohjanvirta R; Huitu O; Henttonen H; Rautio A; Viitala P; Viluksela M
Environ Toxicol Chem; 2012 Mar; 31(3):663-71. PubMed ID: 22213473
[TBL] [Abstract][Full Text] [Related]
19. Subchronic Exposure of [3H]- 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female B6C3F1 mice: relationship of steady-state levels to disposition and metabolism.
Diliberto JJ; DeVito MJ; Ross DG; Birnbaum LS
Toxicol Sci; 2001 Jun; 61(2):241-55. PubMed ID: 11353133
[TBL] [Abstract][Full Text] [Related]
20. CYP1A2 is not required for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunosuppression.
Smialowicz RJ; Burgin DE; Williams WC; Diliberto JJ; Setzer RW; Birnbaum LS
Toxicology; 2004 Apr; 197(1):15-22. PubMed ID: 15003330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
